For rare cancers, challenges in establishing standard therapies are greater than those for major cancers and effective methods are needed. MASTER KEY project is a multicenter study based in Japan, with two main parts prospective registry study and multiple clinical trials. Advanced rare cancers, cancers of unknown primary origin, and those with…[Read more]